In the study, 51.9% of ZTlido® patients experienced decreased or discontinued opioid use, compared to 45.5% with the 5% patch, with more ZTlido® patients reporting at least a 20% reduction in ...

The retrospective claims data, published by Pain Medicine News in its December edition, compared ZTlido® with the generic 5% lidocaine patch. The study analyzed patient claims from the Optum ...

The retrospective claims data, published by Pain Medicine News in its December edition, compared ZTlido® with the generic 5% lidocaine patch. The study analyzed patient claims from the Optum database ...

More patients treated with ZTlido ® saw either a decrease or discontinuation of opioid use compared with those treated with the 5% patch (51.9% vs. 45.5%). Of all study patients reporting a decrease ...

PALO ALTO, Calif. - The U.S. Bankruptcy Court for the Southern District of Texas has approved an extension of the lock-up period for Scilex Holding Company's (NASDAQ: SCLX) Dividend Stock to April 14, ...